# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0906146623798821	Range of duration = 0.2 to 357.37, nDeath = 91, nCensor = 86
2	AGE	ANOVA	0.132352369036802	Range of values = 18 to 87, Mean = 56.0447, StdDev = 15.9968, nMissing = 1
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.096938326564522	nTypes = 4 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 27/1/36/116
4	GENDER	Fisher's exact test	0.107687478209595	nTypes = 2 (FEMALE/MALE), nPatients = 70/110
5	DISTANT.METASTASIS	Chi-square test	0.534753045583084	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 157/2/2/2/2, nMissing = 15
6	LYMPH.NODE.METASTASIS	Chi-square test	0.207523112198725	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 98/2/8/16/1/4/12/5/18/2, nMissing = 14
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 180
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.318066237847495	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 4/18/10/15/19/9/10/8/10/6/19/25/6, nMissing = 21